Senior insider sale
Chief Financial Officer at ULTRAGENYX PHARMACEUTICAL INC. — senior position signals high conviction
$383.3K
14.05K shares
What this filing means
HORN HOWARD plans to sell 14.05K shares of ULTRAGENYX PHARMACEUTICAL INC. valued at approximately $383.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/3/2026ACC: 0001950047-26-007510
Officer· Chief Financial Officer
Since Mar 2026
14.05K
Shares to sell
$383.3K
Approx. market value
4.70K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock and Performance Shares
Not Applicable
3/1/2025
4.70KTotal acquired4.70K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/1/2025 | Restricted Stock and Performance Shares Not Applicable | 4.70K | — |
| Total | 4.70K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
4.70K
Market value
$155.6K
7/1/2026
—Completed
Units to sell
4.65K
Market value
$110.6K
6/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.70K
Market value
$117.0K
8/3/2026
Total
Units
14.05K
Value
$383.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/1/2026 | 4.70K | $155.6K | — | Completed |
6/1/2026 | 4.65K | $110.6K | — | Completed |
| Planned — Approximate Date | ||||
8/3/2026 | 4.70K | $117.0K | NASDAQ | Planned |
| Total | 14.05K | $383.3K | ||